- Home
- LOCO vs BBNX Comparison
LOCO vs BBNX Comparison
Compare LOCO & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LOCO | BBNX |
|---|---|---|
| Founded | 1980 | 2015 |
| Country | United States | United States |
| Employees | N/A | 423 |
| Industry | Restaurants | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 411.3M | 493.1M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | LOCO | BBNX |
|---|---|---|
| Price | $15.93 | $15.85 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 10 |
| Target Price | $14.17 | ★ $23.80 |
| AVG Volume (30 Days) | 251.9K | ★ 994.2K |
| Earning Date | 05-07-2026 | 04-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 4.65 | N/A |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $401,701,000.00 | N/A |
| Revenue This Year | $3.60 | $34.90 |
| Revenue Next Year | $3.98 | $34.63 |
| P/E Ratio | $57.19 | ★ N/A |
| Revenue Growth | ★ 5.68 | N/A |
| 52 Week Low | $8.99 | $8.80 |
| 52 Week High | $17.40 | $32.71 |
Technical Indicators
Market Signals| Indicator | LOCO | BBNX |
|---|---|---|
| Relative Strength Index (RSI) | 47.85 | 50.51 |
| Support Level | $15.84 | $9.34 |
| Resistance Level | $17.21 | $32.52 |
| Average True Range (ATR) | 0.41 | 1.17 |
| MACD | -0.18 | -0.25 |
| Stochastic Oscillator | 30.36 | 18.16 |
Price Performance
Historical ComparisonAbout LOCO El Pollo Loco Holdings Inc.
El Pollo Loco Holdings Inc operates and franchises hundreds of fast-casual chicken restaurants in the United States. It specializes in fire-grilling citrus-marinated chicken and operates in the limited service restaurant market segment. Its offerings include Mexican-inspired menu items, including burritos, tostadas, bowls, salads, and bone-in chicken meals in various portion sizes. It also offers citrus-marinated fire-grilled chicken, along with a range of salsas and dressings that allow customers to customize their meals. The company operates in one operating segment. The majority of the company's revenue is derived from company-operated restaurant revenue.
About BBNX Beta Bionics Inc.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.